These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [LEUKOCYTIC FIBRINOLYSIS]. CAVIEZEL O; VOLLERY M; VANNOTTI A Schweiz Med Wochenschr; 1964 Jul; 94():1016-20. PubMed ID: 14243603 [No Abstract] [Full Text] [Related]
4. SOME PROPERTIES OF THE ANTIFIBRINOLYTICALLY ACTIVE ISOMER OF AMINO-METHYLCYCLOHEXANE CARBOXYLIC ACID. DUBBER AH; MCNICOL GP; DOUGLAS AS; MELANDER B Lancet; 1964 Dec; 2(7373):1317-9. PubMed ID: 14224037 [No Abstract] [Full Text] [Related]
5. ACTION OF THE NEW ANTI-FIBRINOLYTIC SUBSTANCE ON THE STREPTOKINASE-ACTIVATED PROTEASES (PLASMINS). MIHARA H Kobe J Med Sci; 1963 Dec; 18():169-77. PubMed ID: 14160537 [No Abstract] [Full Text] [Related]
6. [THROMBOLYTIC THERAPY AND CHANGES IN FIBRINOLYTIC ACTIVITY]. DOUGLAS AS; MCNICOL GP Recenti Prog Med; 1964 Sep; 37():189-217. PubMed ID: 14229145 [No Abstract] [Full Text] [Related]
7. [60 YEARS OF FIBRINOLYSIS]. MARCHAL G Hemostase; 1963; 3():101-4. PubMed ID: 14050807 [No Abstract] [Full Text] [Related]
8. POSTOPERATIVE CHANGES IN THE COAGULATION FACTORS AND THE FIBRINOLYTIC SYSTEM. OLOW B Scand J Clin Lab Invest; 1964; 16():SUPPL 78:30-3. PubMed ID: 14199706 [No Abstract] [Full Text] [Related]
9. INHIBITION OF FIBRINOLYSIS AND FIBRINOGENOLYSIS IN MAN: COMPARISON OF EPILSON-AMINOCAPROIC AID AND KALLIKREIN INHIBITOR. BECK E; SCHMUTZLER R; DUCKERT F Thromb Diath Haemorrh; 1963 Nov; 10():106-19. PubMed ID: 14081273 [No Abstract] [Full Text] [Related]
10. ACTIVATION OF PARTIALLY PURIFIED PLASMINOGEN IN THE PRESENCE OF EPSILON-AMINOCAPROIC ACID. A TECHNIQUE FOR PREPARING PLASMIN FREE OF EXTRINSIC ACTIVATORS. DONALDSON VH J Lab Clin Med; 1964 Feb; 63():213-23. PubMed ID: 14125108 [No Abstract] [Full Text] [Related]
11. THROMBOLYTIC THERAPY. DOUGLAS AS; MCNICOL GP Proc R Soc Med; 1964 Jul; 57(7):609-14. PubMed ID: 14178954 [No Abstract] [Full Text] [Related]
12. THE ASSAY OF UROKINASE PREPARATIONS FOR CONTAMINATION WITH THROMBOPLASTIC MOIETIES. ALKJAERSIG N; FLETCHER AP; SHERRY S J Lab Clin Med; 1965 May; 65():732-8. PubMed ID: 14281369 [No Abstract] [Full Text] [Related]
13. ROLE OF INHIBITORS OF FIBRINOLYSIS IN HEPATIC CIRRHOSIS. O'CONNELL RA; GROSSI CE; ROUSSELOT LM Lancet; 1964 Nov; 2(7367):990-1. PubMed ID: 14201669 [No Abstract] [Full Text] [Related]
14. THE EUGLOBULIN METHOD FOR ESTIMATION OF FIBRINOLYTIC ACTIVITY IN UROKINASE-ACTIVATED PLASMA, AND THE INFLUENCE OF TRASYLOL. BLIX S Scand J Clin Lab Invest; 1964; 16():198-200. PubMed ID: 14161857 [No Abstract] [Full Text] [Related]
15. FIBRINOLYSIS AND THE PLASMA PROTEIN ELECTROPHORETIC PATTERN. BIELAWIEC M; NILSSON IM Scand J Clin Lab Invest; 1964; 16():513-20. PubMed ID: 14209211 [No Abstract] [Full Text] [Related]
16. [EFFECT OF FIBRINOLYTIC ACTION FOUND IN ASCITES OF EHRLICH CANCER CELL IN MICE]. HIRATA T Kobe Ika Daigaku Kiyo; 1963 Dec; 25():1-9. PubMed ID: 14117791 [No Abstract] [Full Text] [Related]
17. EFFECTS OF FEMALE HORMONES, USED AS ORAL CONTRACEPTIVES, ON THE FIBRINOLYTIC SYSTEM IN BLOOD. BRAKMAN P; ASTRUP T Lancet; 1964 Jul; 2(7349):10-2. PubMed ID: 14149193 [No Abstract] [Full Text] [Related]
18. STUDIES ON THE RELATIONSHIP BETWEEN FIBRIN-STABILIZING FACTOR, CALCIUM AND INHIBITION OF FIBRINOLYSIS. TYLER HM; LACK CH Clin Sci; 1965 Jun; 28():527-36. PubMed ID: 14316258 [No Abstract] [Full Text] [Related]
19. THROMBOLYTIC THERAPY. DOUGLAS AS; MCNICOL GP Br Med Bull; 1964 Sep; 20():228-32. PubMed ID: 14209763 [No Abstract] [Full Text] [Related]
20. CLINICAL TRIAL OF EPSILON-AMINOCAPROIC ACID IN SEVERE HAEMOPHILIA. GORDON AM; MCNICOL GP; DUBBER AH; MCDONALD GA; DOUGLAS AS Br Med J; 1965 Jun; 1(5451):1632-5. PubMed ID: 14295319 [No Abstract] [Full Text] [Related] [Next] [New Search]